Back

Validation of the friedewald and martin-hopkins equations against direct LDL-C measurement in Brazilian adolescents

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Lipoproteins and coronary artery disease (2) Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Romullo Ataides

Johns Hopkins, Baltimore (United States of America)

6 More presentations in this session

Presentation thumbnail
Electronegative remnant lipoproteins drive endothelial and immune cytotoxicity: pathogenic effects of i5 and total Lp5 subfractions
Professor C. Chen (Houston, US)
Abstract Slides Video
Presentation thumbnail
Family history of premature coronary artery disease is linked to unhealthy dietary patterns and lower levels of unsaturated fatty acids.
Doctor K. Osadnik (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Direct measurement vs. Friedewald, Martin-Hopkins and Sampson-NIH equations for LDL-C estimation in Polish primary care population
Associate Professor T. Osadnik (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Eicosapentaenoic acid (EPA) limits rapid oxidation of lipoprotein(a) [Lp(a)] yielding favorable changes in endothelial cell protein expression that may contribute to clinical benefits
Doctor P. Mason (Boston, US)
Abstract Slides Video
Presentation thumbnail
Cardiovascular risk and LDL-C target attainment in cardiology inpatients: insights from the CARDIO study
Doctor A. Samaras (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and coronary artery disease (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating low-density lipoprotein cholesterol (LDL-C) equations in young adulthood for long-term risk of atherosclerotic cardiovascular disease: Superior performance of the Martin-Hopkins equation
29 August 2026
thumbnail
Congress Presentation
Contemporary paediatric lipid percentiles in 5–14-year-olds: a population-based cross-sectional analysis
31 August 2026
thumbnail
Congress Presentation
Effects of a cardiometabolic intervention program in population at high cardiovascular risk. A Brazilian cohort.
28 August 2026
thumbnail
Congress Presentation
Efficacy and safety of alirocumab in children and adolescents with heterozygous familial hypercholesterolaemia inadequately controlled with statins
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources